The Miami Entrepreneur

FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades

Read Time:7 Second

The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia. 

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post DirecTV and Dish Near Deal That Has Eluded Them for Years
Next post Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims